Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.

Ep114: Chris Gibson on Industrializing Drug Discovery

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. 

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Science

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Share Ep114: Chris Gibson on Industrializing Drug Discovery

Sign up to save your podcasts

Ep114: Chris Gibson on Industrializing Drug Discovery

Ep114: Chris Gibson on Industrializing Drug Discovery

More shows like The Long Run with Luke Timmerman

Freakonomics Radio

Odd Lots

The a16z Show

About Men Radio

The Bio Report

How I Built This with Guy Raz

POP | TECH | JAM

Strings and Things

The Readout Loud

The Journal.

Biotech 2050 Podcast

All-In with Chamath, Jason, Sacks & Friedberg

Business Of Biotech

BioCentury This Week

Raising Health

Biotech Hangout

The BioCentury Show

The Workup

Cheeky Pint